供应商 · 研究机构 · 发现——同类成熟企业
Liselo Labs
Liselo 通过伙伴合作和纳米技术、生物技术、信息科学、认知科学(NBIC)的融合应用,释放并放大非洲创新的潜在价值。
简介
供应的生物解决方案 1
产品与服务
产品: Wildlife Research in Africa; Polyclonal IgY Antibodies; Recombinant Proteins; Antibody-based diagnostics and therapeutics; PCR diagnostics; Immunotherapeutic drug for COVID-19; VLP vaccines; Rotaviral infections pre-exposure prophylaxis; Cervical Cancer vaccines; Antivenoms and topical remedies
认证: Medical Devices Manufacturer Registered with SAPRHA
- 应用
- Therapeutic antibody production · Human therapeutics · Animal vaccine manufacture · Agricultural diagnostics · Veterinary therapeutics · Primary healthcare · disease management · pest management · identification · intervention management · reporting
- 认证(官网)
- Medical Devices Manufacturer Registered with SAPRHA
- 客户与合作伙伴
- Lesotho Department of Agriculture · North West Agriculture Department, South Africa · Biopharming Research Unit, University of Cape Town · Entomology Department, University of the North West · Centre for Nanoscale Systems, Harvard University · Central University of Technology, Free State · University of Kwa-Zulu Natal · Council for Scientific and Industrial Research (CSIR) · Imperial College London’s Chanjo Hub · NuGrainSA Consortium · developing world
- 生产基地
- South Africa · Lesotho · Namibia · Botswana · Angola · Lesotho — cGMP capacity currently being expanded; Recombinant proteins · CSIR — Industrial scale; Novel, cost-effective manufacturing methods
- 产品(官网)
- Wildlife Research in Africa — Soft cover R280, ISBN number, Published by Fact and Faith Publications · Polyclonal IgY Antibodies — Custom polyclonal antibodies against a broad range of target antigens, generated within 6-12 weeks. · Recombinant Proteins — Plant-made recombinant proteins produced in N. benthamiana for human therapeutics and animal vaccine manufacture. · Antibody-based diagnostics and therapeutics — Range of antibody-based diagnostics and therapeutics targeting agricultural, veterinary, and primary healthcare challenges. · PCR diagnostics — Deployed across SADC in response to the COVID-19 pandemic. · Immunotherapeutic drug for COVID-19 — Candidate drug for severe COVID-19 cases and post-acute sequelae of SARS CoV-2. · VLP vaccines — African Horse Sickness Virus, Rift Valley Fever Virus, Influenza A and B vaccines. · Rotaviral infections pre-exposure prophylaxis — Candidate drug for prevention of rotaviral infections. · Cervical Cancer vaccines — Pre and post-exposure vaccination for cervical cancer. · Antivenoms and topical remedies — For venomous snakes of Southern Africa. · Antibiotic replacements — For animal feed. · _E.coli_ vaccine — For poultry.
摘自公司官网: about · products · production · quality · rnd · leadership · contact · topic
新闻与状态 6
- 2024-08 最新状态: 公司持续开展研发运营:2024年8月获得新的政府资助,10月完成伦理委员会登记。 ↗ ↗ ↗
- 2025-01-30 Plant-based vaccines could expand access across Africa | Imperial News | Imperial College LondonLiselo Labs, alongside Imperial College London and CSIR, is co-authoring and contributing to the effort to scale plant-based vaccine manufacturing from the lab to full-scale production, as part of the Chanjo Hub initiative.
- 2026-01-06 Southern Africa: A pragmatic reset to unlock South Africa–Taiwan tech cooperation - allAfrica.comLiselo Labs is a project or organization connected to empowering Africa’s growth, with leadership that emphasizes youth participation in Africa’s economic future and holds board roles (including on the BBBEE ICT Council) to advance ICT initiatives.
- 2025-01-30 Plant-based Vaccines Could Expand Access Across Africa | Mirage NewsLiselo Labs, represented by David Jarvis, is part of the international team advancing plant-based vaccine manufacture toward full-scale production, collaborating with Imperial’s Chanjo Hub to build manufacturing networks in Africa.
- 2026-01-13 Southern Africa: A pragmatic reset to unlock South Africa–Taiwan tech cooperation - News | Africa NewsLiselo Labs is mentioned as part of Liselo Labs? It refers to the person (likely a founder or executive) described as a South African entrepreneur involved in unlocking Africa’s growth potential, serving on multiple boards (including the BBBEE ICT Council and …
- 2025-04-08 Commercialization of a sorghum probiotic drink (Niselo) - Universities South AfricaNiselo is a sorghum probiotic drink developed by Nutrigi (a Tshwane University of Technology startup) using a SANBio grant; it has been scaled for distribution in South Africa and Botswana, received international funding and recognition (Scottish Inward …
- 2026-09-23 SA’s HisWay Labs secures funding to help rebuild rail reliability - Disrupt AfricaThe article does not mention Liselo Labs at all; it focuses on HisWay Labs and its TrackView rail-integrity system securing funding and expanding internationally.
关系网络:股东、合作伙伴、同类
股权与投资方 1
| 母公司 | Independent |
合作与交易 5
| 交易对手 | Council for Scientific and Industrial Research (CSIR) …The company has continued its research and development operations, including receiving new government funding in August 2024 and ethics committee registration in October 2024.… |
| 交易对手 | Chanjo Hub …The company has continued its research and development operations, including receiving new government funding in August 2024 and ethics committee registration in October 2024.… |
| 交易对手 | Sartorius …The company has continued its research and development operations, including receiving new government funding in August 2024 and ethics committee registration in October 2024.… |
| 交易对手 | Delta partners …The company has continued its research and development operations, including receiving new government funding in August 2024 and ethics committee registration in October 2024.… |
| 合作 | Bengo Systems …ile and data tools: Mipha “One Health” app (maps, dashboards, tutorials) and a mobile app development partnership (Bengo Systems) to connect diagnostics, monitoring, and stakeholder engagement.
- …… |
同类企业
Minapharm Pharmaceuticals · AGBL Group · Afrigen Biologics (Pty) Ltd · IQVIA Middle East and Africa · AGITECH · PHARAON HEALTHCARE AFRICA · Co-creation HUB (CcHUB) Limited · Gennecs Pharmaceuticals
身份与联系方式
联系方式、人员和法律信息仅向会员开放。
会员登录